Prudential Financial Inc Amneal Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 913,581 shares of AMRX stock, worth $8.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

913,581

Previous 907,371 0.68%

Holding current value

$8.25 Million

Previous $5.76 Million 31.92%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $39,868 - $54,834	6,210 Added 0.68%	913,581 $7.6 Million
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $11,658 - $15,464	2,175 Added 0.24%	907,371 $5.76 Million
Q1 2024 May 14, 2024	SELL	$5.24 - $6.34 $645,201 - $780,644	-123,130 Reduced 11.97%	905,196 $5.49 Million
Q4 2023 Feb 13, 2024	SELL	$3.36 - $6.21 $853,776 - $1.58 Million	-254,100 Reduced 19.81%	1,028,326 $6.24 Million
Q3 2023 Nov 13, 2023	SELL	$2.76 - $4.59 $494,315 - $822,069	-179,100 Reduced 12.25%	1,282,426 $5.41 Million
Q2 2023 Aug 11, 2023	BUY	$1.33 - $3.1 $351,864 - $820,136	264,560 Added 22.1%	1,461,526 $4.53 Million
Q1 2023 May 12, 2023	BUY	$1.27 - $2.7 $349,567 - $743,175	275,250 Added 29.86%	1,196,966 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $235,690 - $313,852	120,250 Added 15.0%	921,716 $0
Q3 2022 Nov 04, 2022	BUY	$2.02 - $3.62 $943,946 - $1.69 Million	467,300 Added 139.84%	801,466 $1.62 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $86,387 - $128,002	-28,700 Reduced 7.91%	334,166 $1.06 Million
Q1 2022 May 13, 2022	SELL	$3.9 - $4.89 $415,584 - $521,078	-106,560 Reduced 22.7%	362,866 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $1.45 Million - $2.15 Million	-367,233 Reduced 43.89%	469,426 $2.25 Million
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $1.06 Million - $1.39 Million	-247,093 Reduced 22.8%	836,659 $4.47 Million
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $1.1 Million - $1.47 Million	-215,362 Reduced 16.58%	1,083,752 $5.55 Million
Q1 2021 May 12, 2021	SELL	$4.74 - $7.38 $350,518 - $545,743	-73,949 Reduced 5.39%	1,299,114 $8.74 Million
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $3,160 - $4,336	-800 Reduced 0.06%	1,373,063 $6.27 Million
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $596,946 - $888,674	168,629 Added 13.99%	1,373,863 $5.33 Million
Q2 2020 Aug 12, 2020	BUY	$2.87 - $5.46 $657,560 - $1.25 Million	229,115 Added 23.47%	1,205,234 $5.74 Million
Q1 2020 May 12, 2020	BUY	$2.46 - $5.35 $148,187 - $322,278	60,239 Added 6.58%	976,119 $3.4 Million
Q4 2019 Feb 11, 2020	SELL	$2.65 - $5.56 $12,476 - $26,176	-4,708 Reduced 0.51%	915,880 $4.41 Million
Q3 2019 Nov 13, 2019	BUY	$2.29 - $7.1 $2.11 Million - $6.54 Million	920,574 Added 6575528.5%	920,588 $2.67 Million
Q2 2019 Aug 05, 2021	SELL	$6.44 - $14.29 $103,020 - $228,597	-15,997 Reduced 99.91%	14 $0
Q2 2019 Aug 08, 2019	BUY	$6.44 - $14.29 $88,092 - $195,472	13,679 Added 586.58%	16,011 $0
Q1 2019 Aug 05, 2021	SELL	$11.87 - $14.84 $154,654 - $193,350	-13,029 Reduced 84.82%	2,332 $33,000
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $171,307 - $214,170	14,432 Added 1553.5%	15,361 $0
Q4 2018 Aug 05, 2021	SELL	$13.09 - $21.49 $208,549 - $342,378	-15,932 Reduced 94.49%	929 $13,000
Q4 2018 Feb 07, 2019	BUY	$13.09 - $21.49 $216,351 - $355,186	16,528 Added 4963.36%	16,861 $228,000
Q3 2018 Sep 01, 2021	SELL	$16.4 - $24.27 $273,519 - $404,775	-16,678 Reduced 98.04%	333 $7,000
Q3 2018 Nov 07, 2018	BUY	$16.4 - $24.27 $277,356 - $410,454	16,912 Added 17082.83%	17,011 $0
Q2 2018 Sep 01, 2021	SELL	$13.95 - $20.2 $249,732 - $361,620	-17,902 Reduced 99.45%	99 $2,000
Q2 2018 Aug 13, 2018	BUY	$13.95 - $20.2 $251,113 - $363,620	18,001 New	18,001 $0

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.37B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Amneal Pharmaceuticals, Inc. Transaction History